Cancer Rop Co. Ltd. (180400) — Cash Flow Reinvestment Rate

Latest as of December 2022: 4.66x

Cancer Rop Co. Ltd. (180400) has a Cash Flow Reinvestment Rate of 4.66x as of December 2022, reinvesting ₩4.03 Billion (capex ₩1.74 Billion plus investments ₩2.30 Billion) from operating cash flow of ₩865.55 Million. Check 180400 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

4.66x
(Capex + Investments) / Operating CF

Total Reinvested

₩4.03 Billion
Capex + Investments

Operating Cash Flow

₩865.55 Million
KRW

Capital Expenditures

₩1.74 Billion
KRW

Cancer Rop Co. Ltd. Cash Flow Reinvestment Rate (2014–2022)

Historical reinvestment intensity for Cancer Rop Co. Ltd. across 2 annual periods. Explore 180400 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Cancer Rop Co. Ltd. (2014–2022)

Year-by-year capital reinvestment analysis for Cancer Rop Co. Ltd.. For live market cap and broader valuation context, see how much is Cancer Rop Co. Ltd. worth.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2022 4.66x ₩4.03 Billion ₩865.55 Million ₩1.74 Billion ▲ +1015.3%
2014 0.42x ₩327.62 Million ₩783.83 Million ₩316.72 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow